Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| aTYR PHARMA INC | 50,000 | reported | 11 May 2026 | tx 10+153,141−6,000 |
| Jasper Therapeutics, Inc. | 20,000 | reported | 22 Sept 2025 | tx 4+62,500 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 11 May 2026 | GRANT_AWARD | aTYR PHARMA INC | 50,000 | 0.00 USD | deriv |
| 22 Sept 2025 | PURCHASE | Jasper Therapeutics, Inc. | 20,000 | 2.43 USD | |
| 22 Sept 2025 | PURCHASE | Jasper Therapeutics, Inc. | 20,000 | — | deriv |
| 03 Jul 2025 | GRANT_AWARD | Jasper Therapeutics, Inc. | 7,500 | 0.00 USD | deriv |
| 01 May 2025 | GRANT_AWARD | aTYR PHARMA INC | 50,000 | 0.00 USD | deriv |
| 18 Jun 2024 | GRANT_AWARD | Jasper Therapeutics, Inc. | 15,000 | 0.00 USD | deriv |
| 22 May 2024 | GRANT_AWARD | aTYR PHARMA INC | 24,000 | 0.00 USD | deriv |
| 17 May 2023 | GRANT_AWARD | aTYR PHARMA INC | 12,000 | 0.00 USD | deriv |
| 26 Apr 2023 | EXERCISE | aTYR PHARMA INC | 6,000 | — | |
| 26 Apr 2023 | EXERCISE | aTYR PHARMA INC | 6,000 | 0.00 USD | deriv |
| 26 Apr 2022 | GRANT_AWARD | aTYR PHARMA INC | 6,000 | 0.00 USD | deriv |
| 28 Apr 2021 | GRANT_AWARD | aTYR PHARMA INC | 1,428 | 0.00 USD | deriv |
| 06 May 2020 | GRANT_AWARD | aTYR PHARMA INC | 1,428 | 0.00 USD | deriv |
| 28 Jun 2019 | GRANT_AWARD | aTYR PHARMA INC | 2,285 | 0.00 USD | deriv |